Jeddah Health Cluster Two signs a cooperation agreement with Jamjoom Pharma to enhance health awareness
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the leading Saudi companies in the pharmaceutical and healthcare industries. This partnership aims to develop the health services provided to citizens and residents in the Kingdom of Saudi Arabia.
The agreement focuses primarily on raising the level of health awareness among community members through specialized awareness programs. Both parties also seek to exchange expertise and knowledge to support medical staff and develop their professional capabilities, which contributes to improving the quality of healthcare provided in the region.
This step comes within the framework of ongoing national efforts to enhance cooperation between the public and private sectors, in line with the goals of Saudi Vision 2030. The initiative aims to provide innovative pharmaceutical solutions and facilitate patients' access to the best available therapeutic services.
It is expected that this agreement will contribute to fostering innovation in the health sector by leveraging Jamjoom Pharma's expertise in pharmaceutical manufacturing. Work will also be done to launch joint awareness campaigns aimed at promoting healthy lifestyles and preventing chronic diseases.
In conclusion, this collaboration reflects the commitment of Jeddah Health Cluster Two to developing the healthcare system in the Kingdom. Through such partnerships, the health sector strives to achieve the highest standards of quality and excellence to ensure the health and safety of the community.